StonvexLoading…
StonvexStonvexStonvexSide-by-side peer comparison: valuation, growth, margin, and Activity Index.
Theme: biotech · 9 peers
Best-in-column highlighted in green, worst in red. Sorted by Activity Index.
| Rank | Ticker | Price | Day | Mkt Cap | P/E | P/S | Rev YoY | Gross M. | Activity Index |
|---|---|---|---|---|---|---|---|---|---|
| You | NTRA Natera | $218.81 | -2.04% | $31.5B | — | 12.6 | +36.6% | 65.1% | 44 |
| 1 | INSM Insmed | $106.03 | -0.82% | $22.5B | — | 27.5 | +115.1% | 81.8% | 48 |
| 2 |
Fundamentals via Finnhub (TTM). Quotes near real-time. Activity Index is Stonvex's proprietary momentum/sentiment composite, not investment advice.
| $600.66 |
| -2.30% |
| $62.7B |
| 14.2 |
| 4.2 |
| +5.9% |
| 85.7% |
| 46 |
| 3 | ALNY Alnylam Pharmaceuticals | $295.63 | -2.10% | $40.4B | 70.0 | 9.4 | +82.6% | 80.8% | 44 |
| 4 | INCY Incyte | $95.59 | -1.19% | $19.3B | 13.5 | 3.6 | +21.5% | 93.0% | 39 |
| 5 | UTHR United Therapeutics | $544.62 | -2.19% | $23.6B | 18.4 | 7.5 | +5.9% | 86.6% | 38 |
| 6 | BIIB Biogen | $192.23 | -1.92% | $28.5B | 20.8 | 2.9 | +1.2% | 75.5% | 37 |
| 7 | 950220.KQ 950220.KQ | — | — | — | — | — | — | — | — |
| 8 | 950200.KQ 950200.KQ | — | — | — | — | — | — | — | — |
| 9 | RVMD RVMD | $163.68 | +3.94% | $34.8B | — | 3007.1 | — | — | — |